STOCK TITAN

Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Pharnext, a biopharmaceutical company listed on Euronext Paris and Nasdaq, recently released a press release regarding the declaration of voting rights for the company's shares. The company's total shares and voting rights as of December 31, 2023, and January 31, 2024, were disclosed in accordance with the general regulation of French Autorité des Marchés Financiers. The press release provides the ISIN code and symbols for the company's shares on both Euronext and Nasdaq, along with the company's website. The release also explains the calculation of gross voting rights and net voting rights, including the treatment of shares with and without voting rights.
Positive
  • None.
Negative
  • None.


Article 223-16 of general regulation of French Autorité des Marchés Financiers


Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com

DateTotal of shares composing the share capitalTotal of brut (1) voting rights

Total of net (2) voting rights

December 31, 20236 075 1056 226 9826 226 733
January 31, 20246 075 1056 227 0026 226 753

(1)   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.

Attachment


FAQ

What is the ISIN code for Pharnext's shares on Euronext Paris?

The ISIN code for Pharnext's shares on Euronext Paris is FR001400K4B1.

What is the symbol for Pharnext's shares on Nasdaq?

The symbol for Pharnext's shares on Nasdaq is PHXM.

How many shares composed Pharnext's share capital as of January 31, 2024?

As of January 31, 2024, Pharnext's share capital consisted of 6,075,105 shares.

What is the website of Pharnext?

The website of Pharnext is www.phaxiam.com.

What is the significance of gross voting rights number in the press release?

The gross voting rights number is used as a basis for calculating the crossing of the threshold, as per the general regulation of Autorité des Marchés Financiers.

How are net voting rights calculated in the press release?

Net voting rights are calculated based on the total shares composing the share capital, excluding treasury shares.

What is the purpose of disclosing the total shares and voting rights in the press release?

The purpose is to comply with the regulation of French Autorité des Marchés Financiers regarding the declaration of voting rights for the company's shares.

What market segments is Pharnext listed on?

Pharnext is listed on Market segment C of Euronext Paris and the Nasdaq Global Select Market in the United States.

PHAXIAM Therapeutics S.A.

NASDAQ:PHXM

PHXM Rankings

PHXM Latest News

PHXM Stock Data

19.86M
6.07M
2.69%
0.02%
Biotechnology
Healthcare
Link
France
Lyon